Bankrupt Rite Aid’s Elixir business ripe for mid-market PE buyout

MedImpact Healthcare has a $575m stalking horse bid to acquire Rite Aid's Elixir pharmacy benefit manager business.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


New to PE Hub?

Register now to read this article and more for free.